Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.
J Clin Oncol
; 25(16): 2171-7, 2007 Jun 01.
Article
em En
| MEDLINE
| ID: mdl-17538161
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Carcinoma de Células Escamosas
/
Receptores ErbB
/
Neoplasias de Cabeça e Pescoço
/
Anticorpos Monoclonais
/
Antineoplásicos
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article